The invention comprises methods for identifying agents that can activate <i>C. elegans</i> DAF-16 and human homologs thereof, or their corresponding genes, whereby cytoprotective effects in cells may be induced. Such cytoprotective effects can result in enhanced environmental stress resistance, increased life span and improved late life vigor without significant inhibition of insulin-signaling pathways. The invention also comprises the therapeutic agents identified and methods of treatment using the agents.
申请公布号
WO0118549(A1)
申请公布日期
2001.03.15
申请号
WO2000US24487
申请日期
2000.09.07
申请人
NEUROGENETICS, INC.;HENDERSON, SAMUEL, T.;JOHNSON, THOMAS, E.